Adenosine deaminase regulates Treg expression in autologous T cell-dendritic cell cocultures from patients infected with HIV-1
- 26 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 99 (2) , 349-359
Abstract
Regulatory T cells have an important role in immune suppression during HIV-1 infection. As regulatory T cells produce the immunomodulatory molecule adenosine, our aim here was to assess the potential of adenosine removal to revert the suppression of anti-HIV responses exerted by regulatory T cells. The experimental setup consisted of ex vivo cocultures of T and dendritic cells, to which adenosine deaminase, an enzyme that hydrolyzes adenosine, was added. In cells from healthy individuals, adenosine hydrolysis decreased CD4+CD25hi regulatory T cells. Addition of 5′-N-ethylcarboxamidoadenosine, an adenosine receptor agonist, significantly decreased CD4+CD25lo cells, confirming a modulatory role of adenosine acting via adenosine receptors. In autologous cocultures of T cells with HIV-1-pulsed dendritic cells, addition of adenosine deaminase led to a significant decrease of HIV-1-induced CD4+CD25hi forkhead box p3+ cells and to a significant enhancement of the HIV-1-specific CD4+ responder T cells. An increase in the effector response was confirmed by the enhanced production of CD4+ and CD8+ CD25−CD45RO+ memory cell generation and secretion of Th1 cytokines, including IFN-γ and IL-15 and chemokines MIP-1α/CCL3, MIP-1β/CCL4, and RANTES/CCL5. These ex vivo results show, in a physiologically relevant model, that adenosine deaminase is able to enhance HIV-1 effector responses markedly. The possibility to revert regulatory T cell-mediated inhibition of immune responses by use of adenosine deaminase, an enzyme that hydrolyzes adenosine, merits attention for restoring T lymphocyte function in HIV-1 infection.Keywords
Funding Information
- Fundación para la Investigación y la Prevención del Sida en España (36750/08)
- Fondo de Investigación Sanitaria (PS09/01297, PI10/02984)
- Spanish Ministry of Science (SAF2006-26667-E, 2012-39075)
- Catalonian Center for HIV-1 Vaccines
- HIVACAT
- American Foundation for AIDS Research (108821-55-RGRL)
- EU FP7 Program (602570-2)
- Spanish Ministry of “Economía y Competitividad.”
- facilities of the Immunology Section of the Center
- Diagnosis of the Hospital Clínic of Barcelona
- M. C.
This publication has 58 references indexed in Scilit:
- Cross-presentation by dendritic cellsNature Reviews Immunology, 2012
- Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCIDBlood, 2012
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive DiseaseJournal of Virology, 2011
- IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccineCellular & Molecular Immunology, 2010
- Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T CellsJournal of Biological Chemistry, 2010
- Immunological dysfunction in HIV‐1‐infected individuals caused by impairment of adenosine deaminase‐induced costimulation of T‐cell activationImmunology, 2009
- Preserved Central Memory and Activated Effector Memory CD4+T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 StudyJournal of Virology, 2007
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2007
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999